Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D to Prevent Recurrence of Gestational Diabetes
NCT03701087Phase 1Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vitamin d in gestational diabetes mellitus (GDM) (3 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of Gestational Diabetes Recurrence. Status: unknown.
02
Drugs
vitamin d
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT03701087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701087.